Loading the section
Closing prices for 09 October 2026
Next earnings report: 02 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Kenvue Inc. trades on NYSE under the ticker KVUE. The company belongs to the Consumer defensive sector. The trading history on this page starts on 04 May 2023.
Over the past 52 weeks KVUE has traded between 14.02 $ and 20.13 $. As of 09 October 2026 the price stood 60.23 % of the way from the 52-week low to the high.
Over one year KVUE shares rose 10.07 %; over six months they rose 2.02 %. Volatility over 90 days is 22.73 %. Dividends are not included: this is price change only, as of 09 October 2026.
KVUE trades at a price-to-earnings ratio of 21.0, below the sector median of 21.6. Price to sales is 2.2, above the sector median of 0.9. Price to book is 3.2, above the sector median of 2.1. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 17.70 | 17.80 | 17.63 | 17.70 | 24M |
| 08 October 2026 | 17.58 | 17.74 | 17.44 | 17.73 | 23M |
| 07 October 2026 | 17.62 | 17.69 | 17.52 | 17.53 | 12M |
| 06 October 2026 | 17.46 | 17.65 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Kenvue is the consumer brand portfolio spun out of Johnson & Johnson: Tylenol, Listerine, Neutrogena, Band-Aid.
Everyday products from the pharmacy shelf are bought by habit and by name: a painkiller or a plaster is chosen without comparing formulations. That yields steady revenue and the ability to raise prices with inflation. Separating from pharmaceuticals was logical — the two businesses move at different speeds and carry different risks.
On separating, the company also inherited a share of the old problems: talc litigation remains part of the parent structure's legacy and continues to be argued in court. The second challenge is pressure from retailers' own labels, which offer the same active ingredient more cheaply. Kenvue pays a dividend.
Address:1 KENVUE WAY, SUMMIT, NJ, 07901, US
Kenvue Inc. reported revenue of 15.3B $ and net income of 1.6B $ over the last four quarters. Net margin is 10.61 %. Revenue changed by −0.07 % year over year. Earnings per share are 0.84 $. Market capitalisation is 34.0B $.
KVUE has a return on equity of 15.29 %, above the sector median of 6.34 %. Return on assets is 6.04 %, above the sector median of 2.21 %. Operating margin is 17.15 %, above the sector median of 3.58 %.
| 26M |
| IPARInterparfums, Inc. | 111.78 | +0.16 % | 25M |
| EPCEdgewell Personal Care Company | 27.80 | +0.25 % | 16M |
| COTYCoty Inc. | 2.85 | +2.15 % | 14M |
| BNKKBonk, Inc. | 1.43 | 0.00 % | 768,956 |
| 17.41 |
| 17.59 |
| 11M |
| 05 October 2026 | 17.24 | 17.41 | 17.17 | 17.39 | 14M |
| 02 October 2026 | 17.33 | 17.38 | 17.16 | 17.20 | 14M |
| 01 October 2026 | 17.43 | 17.55 | 17.19 | 17.22 | 22M |
| 30 September 2026 | 18.08 | 18.08 | 17.66 | 17.66 | 25M |
| 29 September 2026 | 17.74 | 17.93 | 17.70 | 17.91 | 19M |
| 28 September 2026 | 17.73 | 17.90 | 17.65 | 17.88 | 16M |
| 25 September 2026 | 17.59 | 17.84 | 17.56 | 17.80 | 13M |
| 24 September 2026 | 17.77 | 17.88 | 17.61 | 17.61 | 17M |
| 23 September 2026 | 17.84 | 17.90 | 17.64 | 17.67 | 16M |
| 22 September 2026 | 17.95 | 17.99 | 17.84 | 17.86 | 14M |
| 21 September 2026 | 17.63 | 17.73 | 17.49 | 17.67 | 26M |
| 18 September 2026 | 17.80 | 17.97 | 17.76 | 17.81 | 27M |
| 17 September 2026 | 17.98 | 18.10 | 17.78 | 17.87 | 23M |
| 16 September 2026 | 17.99 | 18.06 | 17.76 | 17.83 | 23M |
| 15 September 2026 | 17.93 | 17.94 | 17.70 | 17.92 | 54M |
| 14 September 2026 | 17.91 | 18.20 | 17.87 | 17.91 | 41M |